COVID-19: Mayo Clinic is committed to taking care of our patients, learners and staff as we address the COVID-19 situation. Learn more about COVID-19 online education, resources, and live course cancellations.



This series of 90-minute webinars features Mayo Clinic experts discussing monoclonal antibodies and other novel therapeutics in COVID-19 treatment. Webinar recordings will be available within 48 hours.

Upcoming Webinars

Live MAY 26 Webinar - REGISTER

Monoclonal Antibody Therapy for COVID-19: What You Need to Know

On Wednesday, May 26, from 8:30 a.m. – 10:00 a.m. CDT, Mayo Clinic experts will discuss monoclonal antibody treatment in depth, including what it is, how it works, and where it fits in the current treatment of COVID-19.

  • Moderator: Claudia R. Libertin, M.D., consultant, Division of Infectious Diseases; professor of medicine
  • Featured expert: Leigh L. Speicher, M.D., M.P.H., consultant, Division of General Internal Medicine; assistant professor of medicine
  • Featured expert: Lisa Brumble, M.D., consultant, Division of Infectious Diseases; assistant professor of medicine
  • Featured expert: Kathleen (Kate) A. Rottman Pietrzak, Pharm.D., R.Ph., BCCCP, BCPS, clinical pharmacist; instructor in pharmacy.

Questions for the panel can be submitted via Slido using event code #COVID21.

Live JUNE 30 Webinar - REGISTER

Monoclonal Antibody Therapy for COVID-19: Key Practical Considerations

On Wednesday, June 30, from 9:00 a.m. – 10:30 a.m. CDT,  Mayo Clinic experts discuss logistics and practicalities in treating COVID-19 patients with monoclonal antibodies, as well as monitoring the effects of treatment.

  • Featured Expert: Devyani Lal, M.D., consultant, Division of Otolaryngology, professor of otolaryngology, Associate Dean, Mayo Clinic School of Continuous Professional Development
  • Featured Expert: Jonathan A. Leighton, M.D., consultant, Division of Gastroenterology and Hepatology, professor of medicine
  • Featured Expert: Nita Sharma, operations manager, instructor in health care systems engineering

Questions for the panel can be submitted via Slido using event code #COVID21.

 

Previously Recorded Sessions

Previously Recorded - ONLINE CME COURSE
Live Webinar - CLAIM CME CREDIT

Updates on Recently Authorized Therapies for COVID-19

On Wednesday, April 28, from 8:30 a.m. – 10:00 a.m. CDT, Mayo Clinic experts will review recently authorized therapies for COVID-19, including monoclonal antibody treatment and other novel therapeutics.

  • Moderator: Amit K. Ghosh, M.D., M.B.A., consultant, Division of General Internal Medicine; professor of medicine
  • Featured Expert: Raymund R. Razonable, M.D., FIDSA, FAST, vice chair, Division of Infectious Diseases; program director, Infectious Diseases Fellowship Program; professor of medicine
  • Featured Expert: Ravindra Ganesh, M.B.B.S., M.D., consultant, Division of General Internal Medicine; assistant professor of medicine
  • Featured Expert: Larry Lutwick, M.D., consultant, Division of Infectious Disease, Mayo Clinic Health System – Eau Claire; professor of medicine
  • Featured Expert: Lori Arndt, P.A.-C., Division of Infectious Diseases, Mayo Clinic Health System – Eau Claire
  • Featured Expert: Richard Arndt, Pharm.D., R.Ph., senior manager, Pharmacy Clinical Services, Mayo Clinic Health System – Eau Claire; assistant professor of pharmacy

Learning Objectives

Upon completion of this activity, you will be able to:

  • Explain the effect of neutralizing viral monoclonal bodies on the SARS-COV2 virus
  • Explain how mAb fit in the current paradigm of outpatient medical therapy of COVID-19
  • Explain contraindications for mAb and how to manage reactions and complications from mAb
  • Address logistical requirements for administration of mAb
  • Identify individuals at higher risk of disease progression that might benefit from early administration of mAb
  • Critically evaluate the impact of racial, ethnic, and socio-economic disparities in disease severity and access to optimal therapy for mild-moderate COVID-19
  • Detail logistical requirements from an HCP perspective: Supplies, personnel, training, developing nurse-initiated protocol and processes necessary for administration of mAb
  • Explain logistical requirements for healthcare administrators: Infrastructural needs, facilities management, personal deployment and training, in-facility safety protocols for mAb administration in COVID positive patients

Attendance at any Mayo Clinic course does not indicate or guarantee competence or proficiency in the skills, knowledge or performance of any care or procedure(s) which may be discussed or taught in this course.

Commercial Support

This educational activity is supported in part by an
independent medical education grant from

Eli Lilly and Company

and is in accordance with ACCME guidelines.